Lampertheim, France

Ang Ele Schoenfelder

This inventor holds 1 USPTO granted patent. Top assignees: Eli Lilly and Company, Lilly, Sa, Université Louis Pasteur. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ang Ele Schoenfelder. Retrieved from https://idiyas.com/inventor/ang-ele-schoenfelder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ang Ele Schoenfelder: Innovator in Pharmaceutical Compounds

Introduction

Ang Ele Schoenfelder is a notable inventor based in Lampertheim, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent. His work has implications for the development of new therapeutic compounds.

Latest Patents

Schoenfelder holds a patent for a pharmaceutical compound characterized by a specific formula. The compound includes variables such as m, n, q, and p, which can take on various values, and X can be either a carboxylic acid group or a tetrazolyl group. This patent represents a step forward in pharmaceutical chemistry.

Career Highlights

Throughout his career, Ang Ele Schoenfelder has worked with prominent organizations, including Eli Lilly and Company and Université Louis Pasteur. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Schoenfelder has collaborated with notable colleagues, including Jesus Ezquerra Carrera and Almudena Rubio Esteban. These partnerships have contributed to his innovative work in the pharmaceutical sector.

Conclusion

Ang Ele Schoenfelder's contributions to pharmaceutical compounds highlight his role as an inventor dedicated to advancing medical science. His patent and collaborations reflect his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…